Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

NCT04551898 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
181
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

BeiGene